Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 13 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Neoplasms 4 Lung Neoplasms 4 Brain Neoplasms 4 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Skin Diseases 2 Pancreatic Neoplasms 2 Hematologic Neoplasms 2 Uveal Melanoma 1 Spinocerebellar Degenerations 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Soft Tissue Neoplasms 1 Peripheral Nervous System Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Noonan Syndrome 5 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Multiple Myeloma 1 Lymphoma 1 Lymphatic Metastasis 1 Low-grade Serous Ovarian Cancer 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Gliosarcoma 1

Interventions

Temozolomide 29 Bevacizumab 15 Radiotherapy 13 antineoplaston AS 2-1 8 antineoplaston A10 8 Everolimus 7 Radiation 6 Erlotinib Hydrochloride 6 Radiotherapy, Intensity-Modulated 5 Lomustine 4 veliparib 3 palbociclib 3 Vorinostat 3 Sunitinib 3 Radiotherapy, Conformal 3 Magnetic Resonance Spectroscopy 3 Carmustine 3 Carboplatin 3 temsirolimus 2 selinexor 2 poly ICLC 2 etoposide phosphate 2 cabozantinib 2 Sirolimus 2 Nivolumab 2 Irinotecan 2 Immunoglobulin G 2 Imatinib Mesylate 2 Etoposide 2 Donepezil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Astrocytoma × binimetinib × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡